{"cik":1868734,"taxonomy":"us-gaap","tag":"LiabilitiesCurrent","label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","entityName":"CinCor Pharma, Inc.","units":{"USD":[{"end":"2020-12-31","val":6891364,"accn":"0000950170-22-004307","fy":2021,"fp":"FY","form":"10-K","filed":"2022-03-22","frame":"CY2020Q4I"},{"end":"2021-12-31","val":16549189,"accn":"0000950170-22-004307","fy":2021,"fp":"FY","form":"10-K","filed":"2022-03-22"},{"end":"2021-12-31","val":16549189,"accn":"0000950170-22-009030","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-10"},{"end":"2021-12-31","val":16549189,"accn":"0000950170-22-015254","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-08"},{"end":"2021-12-31","val":16549189,"accn":"0000950170-22-021582","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-03","frame":"CY2021Q4I"},{"end":"2022-03-31","val":5685716,"accn":"0000950170-22-009030","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-10","frame":"CY2022Q1I"},{"end":"2022-06-30","val":7281874,"accn":"0000950170-22-015254","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-08","frame":"CY2022Q2I"},{"end":"2022-09-30","val":10181519,"accn":"0000950170-22-021582","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-03","frame":"CY2022Q3I"}]}}